{"id":13731,"date":"2019-08-02T09:37:11","date_gmt":"2019-08-02T13:37:11","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13731"},"modified":"2019-08-02T09:37:11","modified_gmt":"2019-08-02T13:37:11","slug":"a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13731","title":{"rendered":"A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries"},"content":{"rendered":"<p><span style=\"color: #393d40; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', sans-serif; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;\">The affordability of prescription drugs is a pressing concern for many Americans, with broad agreement across the political spectrum that lowering prescription drug costs should be a top priority for Congress. The Trump Administration, members of Congress, and several 2020 presidential candidates have offered proposals to lower drug prices. Many of these proposals would affect prescription drug spending under Medicare, which accounts for\u00a0<\/span><a style=\"margin: 0px; padding: 0px; border: 0px currentColor; color: #0075c9; text-transform: none; line-height: inherit; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', sans-serif; font-size: 16px; font-style: normal; font-weight: 400; text-decoration: none; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit;\" href=\"https:\/\/www.kff.org\/medicare\/issue-brief\/how-does-prescription-drug-spending-and-use-compare-across-large-employer-plans-medicare-part-d-and-medicaid\/\" target=\"_blank\" rel=\"noopener noreferrer\">30 percent<\/a><span style=\"color: #393d40; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', sans-serif; font-size: 16px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;\">\u00a0of national retail spending on drugs and nearly $1 out of every $5 in total Medicare spending (Figure 1).\u00a0 Continue reading <a href=\"https:\/\/www.kff.org\/medicare\/issue-brief\/a-look-at-recent-proposals-to-control-drug-spending-by-medicare-and-its-beneficiaries\/\">report here&#8230;<\/a><\/span><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7499\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\" alt=\"\" width=\"147\" height=\"138\" \/><\/a><\/p>\n<pre><span style=\"color: #000000; font-family: Calibri;\">Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/span><\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The affordability of prescription drugs is a pressing concern for many Americans, with broad agreement across the political spectrum that<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,6,15],"tags":[],"class_list":["post-13731","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13731"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13731\/revisions"}],"predecessor-version":[{"id":13732,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13731\/revisions\/13732"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}